Can pediatric patients with a history of seizures or an active seizure disorder safely be prescribed bupropion?

Bupropion is Absolutely Contraindicated in Pediatric Patients with Seizure Disorders

Pediatric patients with a history of seizures or an active seizure disorder should NOT be prescribed bupropion under any circumstances. This is an absolute contraindication based on FDA labeling and consistent guideline evidence 1, 2.

The Evidence is Unequivocal

The FDA-approved product label explicitly states that bupropion is contraindicated in patients with a seizure disorder 1. This contraindication applies to all age groups, including pediatric patients. The 2025 American Thoracic Society guideline reinforces this, noting that bupropion is contraindicated in patients with a seizure disorder due to a higher incidence of seizures 1.

Why This Matters for Seizure Risk

Bupropion lowers the seizure threshold through its mechanism of action as a dopamine and norepinephrine reuptake inhibitor 3. The seizure risk is:

• Dose-dependent: Risk increases substantially with higher doses 2, 3
• Approximately 0.1-0.4% in patients without risk factors at therapeutic doses 3, 4
• Dramatically elevated in patients with pre-existing seizure disorders or risk factors 5, 4

Pediatric-Specific Concerns

While bupropion has been used safely in children as young as 6 years for ADHD 1, this safety profile does not extend to children with seizure disorders. Case reports document:

• Status epilepticus in an infant after bupropion ingestion 6
• Multiple seizures and prolonged hospitalization in pediatric overdoses 7, 8
• Delayed seizure onset up to 24 hours post-exposure 7

Clinical Algorithm for Decision-Making

Before prescribing bupropion to ANY pediatric patient:

1. Screen for absolute contraindications:

   • Current seizure disorder → DO NOT PRESCRIBE
   • History of any seizures → DO NOT PRESCRIBE
   • Eating disorders (anorexia/bulimia) → DO NOT PRESCRIBE 2

2. Screen for relative risk factors that increase seizure risk:

   • Head injury or CNS tumor
   • CNS infection or stroke
   • Metabolic disorders (hypoglycemia, hyponatremia)
   • Concurrent medications lowering seizure threshold
   • Abrupt discontinuation of alcohol, benzodiazepines, or antiepileptics 2

3. If any seizure history exists → STOP. Choose alternative therapy.

The Nuance: General Pediatric Use vs. Seizure Disorders

There is an important distinction to understand:

• The 2025 ATS guideline suggests bupropion can be considered for adolescents 10-18 years for nicotine cessation in patients without contraindications 1
• Bupropion has demonstrated safety in pediatric ADHD and depression studies in patients without seizure disorders 1
• However, this conditional recommendation explicitly excludes patients with seizure disorders due to the FDA contraindication 1

Critical Pitfalls to Avoid

1. Do not assume "well-controlled" epilepsy is safe: The contraindication applies regardless of seizure control status
2. Do not rely on anticonvulsant co-administration: Even patients on anticonvulsants with seizure history should not receive bupropion 9
3. Do not underestimate family history: While not an absolute contraindication, strong family history of seizures warrants extreme caution
4. Do not miss medication interactions: Concurrent use of other medications that lower seizure threshold (antipsychotics, tricyclics, theophylline, systemic corticosteroids) compounds risk 2

Alternative Approaches

For pediatric patients with seizure disorders requiring treatment for:

• Depression/ADHD: Consider SSRIs, SNRIs, or stimulants (with appropriate monitoring)
• Nicotine cessation: Consider behavioral interventions, varenicline (though also requires caution), or nicotine replacement therapy 1

The bottom line: A history of seizures in a pediatric patient makes bupropion an unacceptable choice regardless of the indication. The risk of precipitating seizures, including status epilepticus, far outweighs any potential benefit.